Autopsy and Case Reports
https://www.autopsyandcasereports.org/article/doi/10.4322/acr.2021.290
Autopsy and Case Reports
Clinical Case Report

Thoracic duct lymphangioma and chylous ascites in a 24-year-old female

Larissa Moreira Galvão Bello; Vitorino Modesto dos Santos; Márcia Mayumi Marques Suzuki; Naiara Regina Siqueira; Fernanda Gonçalves Reis

http://dx.doi.org/10.4322/acr.2021.290 Autops Case Rep, vol.11, e2021290, 2021
PDF
Downloads: 0
Views: 803

Abstract

Lymphangiomas are rare and correspond to 0.7% to 4.0% of mediastinal tumors, and isolated mediastinal location occurs in 1% of cases. They are benign tumors that originate from a congenital malformation of the lymphatic vessels and are diagnosed more frequently in children less than 2 years of age. Chylous ascites is a clinical manifestation of thoracic duct lymphangioma and is composed of lymph accumulation caused by dilation of this lymphatic channel. It appears milky in the peritoneal cavity, containing triglyceride levels higher than 200 mg/dl. We report the case of a young patient with chylous ascites and lymphangioma of the thoracic duct, who was conservatively treated with octreotide and a low-fat diet with medium-chain triglycerides.

Keywords

Chylous Ascites, Lymphangioma, Octreotide, Thoracic Duct, Treatment

References

1 Salehi F, Landis M, Inculet R, Wiseman D. Case report of a rare cystic mediastinal lymphangioma mimicking recurrent pleural effusion. Case Rep Radiol. 2019;2019:1301845. http://dx.doi.org/10.1155/2019/1301845. PMid:31240145.

2 Hamaguchi Y, Arita S, Sugimoto N, et al. Laparoscopic resection of abdominal cystic lymphangioma derived from lesser omentum: case report. Medicine (Baltimore). 2020;99(1):e18641. http://dx.doi.org/10.1097/MD.0000000000018641. PMid:31895826.

3 Melo IA, Camargo JJ, Gomes BM, Cabrera GA, Machuca TN. Isolated mediastinal cystic lymphangioma. Rev Port Pneumol. 2009;15(4):697-703. http://dx.doi.org/10.1016/S0873-2159(15)30165-3. PMid:19547899.

4 Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous ascites: a review of pathogenesis, diagnosis and treatment. J Clin Transl Hepatol. 2018;6(1):105-13. http://dx.doi.org/10.14218/JCTH.2017.00035. PMid:29577037.

5 Fernandes FF, Alves VO, Sánchez TE, Paula WD, Santana AN. Chylothorax in paracoccidioidomycosis. Rev Inst Med Trop São Paulo. 2016;58(0):57. http://dx.doi.org/10.1590/S1678-9946201658057. PMid:27410917.

6 Javier Uribe M, Rolando Sepúlveda C, Rodrigo Cruz N, et al. Chylous ascites management: clinical case and literature review. Gastroenterol Latinoam. 2018;29(4):193-9.

7 Ghimire S, Shah H, Paudel S, Yang TJM, Khan HM. Chylous ascites and pleural effusion treated with intravenous Octreotide. Cureus. 2020;12(6):e8669. http://dx.doi.org/10.7759/cureus.8669. PMid:32699669.

8 Oré Acevedo JF, La Torre Caballero LM, Urteaga Quiroga RL. Surgical treatment of lymphatic malformations in pediatric patients. Acta Otorrinolaringol Cir Cabeza Cuello. 2020;48(2):165-71. http://dx.doi.org/10.37076/acorl.v48i2.119.

9 Gomes CS, Handa GI, Silveira FP, Buzingnani VZ, Binati FM, Rasera ESL. Tratamento cirúrgico da ascite quilosa. J Vasc Bras. 2009;8(2):192-7. http://dx.doi.org/10.1590/S1677-54492009000200017.

10 Pessotti CFX, Jatene IB, Buononato PEU, Elias PF, Pinto ACD, Kok MFJ. Uso do octreotide no tratamento do quilotórax e quiloperitôneo. Arq Bras Cardiol. 2011;97(2):e33-6. http://dx.doi.org/10.1590/S0066-782X2011001100017. PMid:22002034.

11 Parthasarathy S, Shah S, Raja Sager A, Rangan A, Durugu S. Staphylococcus lugdunensis: review of epidemiology, complications, and treatment. Cureus. 2020;12(6):e8801. http://dx.doi.org/10.7759/cureus.8801. PMid:32617242.
 

Submitted date:
01/18/2021

Accepted date:
04/19/2021

Publication date:
05/27/2021

60af874ca9539509ed066a84 autopsy Articles
Links & Downloads
2236-1960 (Electronic)
Autops Case Rep ©2024 All rights reserved.

Autops Case Rep

Share this page
Page Sections